Valued at a market cap of $18.2 billion, Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the United States and internationally. Founded in 1967 and based in Secaucus, ...

Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $189 from $178 and keeps an Outperform rating on the shares. The firm ...

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and ...

The Quest Diagnostics office, at 1074 Idaho St., will have two phlebotomists when fully staffed and expects to draw blood ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can ...

Quest Diagnostics (DGX) launched a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer’s ...

Looking ahead, industry tailwinds include the expansion of personalized medicine ... Founded in 1967 as MetPath, Quest Diagnostics (NYSE:DGX) is a provider of diagnostic testing services, offering ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.